Ligand profile
KJK
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
KJK- PDB
6td1- UniProt (this protein)
Q9F663- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 133.9
- −1 ≤ LogP ≤ 5 0.32
- MW ≤ 500 Da 389.3
- LogP ≤ 5 0.32
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 133.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B1([C@H](Cc2cccc(c2O1)C(=O)O)NC(=O)CC3CCC(CC3)NCCN)OB1([C@H](Cc2cccc(c2O1)C(=O)O)NC(=O)CC3CCC(CC3)NCCN)O
InChI=1S/C19H28BN3O5/c21-8-9-22-14-6-4-12(5-7-14)10-17(24)23-16-11-13-2-1-3-15(19(25)26)18(13)28-20(16)27/h1-3,12,14,16,22,27H,4-11,21H2,(H,23,24)(H,25,26)/t12?,14?,16-/m0/s1InChI=1S/C19H28BN3O5/c21-8-9-22-14-6-4-12(5-7-14)10-17(24)23-16-11-13-2-1-3-15(19(25)26)18(13)28-20(16)27/h1-3,12,14,16,22,27H,4-11,21H2,(H,23,24)(H,25,26)/t12?,14?,16-/m0/s1
PFZUWUXKQPRWAL-PXCJXSSVSA-NPFZUWUXKQPRWAL-PXCJXSSVSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand KJK →
- PDB RCSB structure 6td1 →
- UniProt UniProt Q9F663 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “KJK”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 35
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).